Accelerating Your Biopharma Startup's Path To The Clinic

(recorded 9/25/20)

Pamela Contag, Ph.D., cofounder and CEO of BioEclipse Therapeutics, a clinical-stage oncology company; and Dara Lockert, founder and executive director of Spannerwerks, a life science industry consultancy, share best practices and lessons learned during the drive to get a biopharmaceutical startup to the clinic as quickly as possible. The discussion, moderated by Rob Wright, chief editor of Life Science Leader, builds upon the wisdom shared by Contag in, “A Small Biopharma’s View Of Working With CROs,” published in the July 2020 CRO Leadership Awards special supplement.